Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virus-infected patients.

John Ziebuhr, Benjamin Koch, Helmut Geiger, Christian Münch, Ursula Dietrich, Tobias Schmid, Mahmoud Shehata, Christin Müller-Ruttloff, Shady A Gouda, Nils Wetzstein, Sammy Patyna, Anica Scholz, Luis Martinez-Sobrido, Patrick C Baer, Ahmed Mostafa, Stephan Pleschka

Journal: Frontiers in cellular and infection microbiology 2024;14():1363407

PMID: 38590437

Abstract

INTRODUCTION

Influenza A virus (IAV) infection can cause the often-lethal acute respiratory distress syndrome (ARDS) of the lung. Concomitantly, acute kidney injury (AKI) is frequently noticed during IAV infection, correlating with an increased mortality. The aim of this study was to elucidate the interaction of IAV with human kidney cells and, thereby, to assess the mechanisms underlying IAV-mediated AKI.

METHODS

To investigate IAV effects on nephron cells we performed infectivity assays with human IAV, as well as with human isolates of either low or highly pathogenic avian IAV. Also, transcriptome and proteome analysis of IAV-infected primary human distal tubular kidney cells (DTC) was performed. Furthermore, the DTC transcriptome was compared to existing transcriptomic data from IAV-infected lung and trachea cells.

RESULTS

We demonstrate productive replication of all tested IAV strains on primary and immortalized nephron cells. Comparison of our transcriptome and proteome analysis of H1N1-type IAV-infected human primary distal tubular cells (DTC) with existing data from H1N1-type IAV-infected lung and primary trachea cells revealed enrichment of specific factors responsible for regulated cell death in primary DTC, which could be targeted by specific inhibitors.

DISCUSSION

IAV not only infects, but also productively replicates on different human nephron cells. Importantly, multi-omics analysis revealed regulated cell death as potential contributing factor for the clinically observed kidney pathology in influenza.

Copyright © 2024 Koch, Shehata, Müller-Ruttloff, Gouda, Wetzstein, Patyna, Scholz, Schmid, Dietrich, Münch, Ziebuhr, Geiger, Martinez-Sobrido, Baer, Mostafa and Pleschka.

Address: Department of Internal Medicine 4, Nephrology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.; Center of Scientific Excellence for Influenza Viruses, National Research Centre (NRC), Cairo, Egypt.; Institute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.; Institute of Medical Virology, Justus Liebig University Giessen, Giessen, Germany.; German Center for Infection Research (DZIF), Partner Site Giessen, Giessen, Germany.; Institute for Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Internal Medicine 2, Infectious Diseases, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute of Biochemistry I, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.; Institute for Biochemistry II, Goethe University Frankfurt, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; Cardio-Pulmonary Institute, Frankfurt am Main, Germany.; Texas Biomedical Research Institute, Disease Intervention & Prevention (DIP) and Host Pathogen Interactions (HPI) Programs, San Antonio, TX, United States.; Center of Scientific Excellence for Influenza Viruses, National Research Centre (NRC), Cairo, Egypt.; Texas Biomedical Research Institute, Disease Intervention & Prevention (DIP) and Host Pathogen Interactions (HPI) Programs, San Antonio, TX, United States.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.